Pharma Fridays – July 18, 2025

July 18, 2025

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Recordati Rare Diseases Announced New Data in Cushing’s Syndrome, Cushing’s Disease, and Post-Bariatric Hypoglycaemia at ENDO 2025 In April 2025, the FDA approved an expanded indication for ISTURISA® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing’s syndrome Recordati Rare […]

To view the full Member Resource, please Log in

TOPICS IN THIS ARTICLE:

Pharma Fridays

←AI-Powered Mobile Retina Tracker Screens for Diabetic Eye Disease with 99% Accuracy

Tightrope: Obesity Management in Women During Reproductive Years→

View Archives

Join the Global Movement Advancing Endocrine Science and Medicine

Become a part of a community of 18,000-plus endocrine investigators and clinicians who conduct research and provide quality patient care in more than 100 countries. Advance your career and the field of endocrinology through our many educational, leadership and advocacy opportunities.

Join Today